首页> 外文期刊>Analytical chemistry >Direct Replacement of Antibodies with Molecularly Imprinted Polymer Nanoparticles in ELISA--Development of a Novel Assay for Vancomycin
【24h】

Direct Replacement of Antibodies with Molecularly Imprinted Polymer Nanoparticles in ELISA--Development of a Novel Assay for Vancomycin

机译:用ELISA中的分子印迹聚合物纳米颗粒直接替换抗体-万古霉素新检测方法的开发

获取原文
获取原文并翻译 | 示例
       

摘要

A simple and straightforward technique for coating microplate wells with molecularly imprinted polymer nanoparticles (nanoMIPs) to develop assays similar to the enzyme-linked immunosorbent assay (ELISA) is presented here for the first time. NanoMIPs were synthesized by a solid-phase approach with an immobilized vancomycin (template) and characterized using Biacore 3000, dynamic light scattering, and electron microscopy. Immobilization, blocking, and washing conditions were optimized in microplate format. The detection of vancomycin was achieved in competitive binding experiments with a horseradish peroxidasevancomycin conjugate. The assay was capable of measuring vancomycin in buffer and in blood plasma within the range of 0.001-70 nM with a detection limit of 0.0025 nM (2.5 pM). The sensitivity of the assay was 3 orders of magnitude better than a previously described ELISA based on antibodies. In these experiments, nanoMIPs have shown high affinity and minimal interference from blood plasma components. Immobilized nanoMIPs were stored for 1 month at room temperature without any detrimental effects to their binding properties. The high affinity of nanoMIPs and the lack of a requirement for cold chain logistics make them an attractive alternative to traditional antibodies used in ELISA.
机译:首次在这里首次提出了一种简单明了的技术,该技术可以用分子印迹聚合物纳米颗粒(nanoMIP)覆盖微孔板,以开发类似于酶联免疫吸附测定(ELISA)的测定方法。通过固定化万古霉素(模板)的固相方法合成NanoMIP,并使用Biacore 3000,动态光散射和电子显微镜对其进行表征。固定,封闭和洗涤条件以微孔板形式进行了优化。在辣根过氧化物酶-万古霉素缀合物的竞争性结合实验中实现了万古霉素的检测。该测定法能够测量0.001-70 nM范围内的缓冲液和血浆中的万古霉素,检测限为0.0025 nM(2.5 pM)。该测定的灵敏度比先前描述的基于抗体的ELISA高3个数量级。在这些实验中,nanoMIPs具有很高的亲和力,并且对血浆成分的干扰最小。固定的nanoMIP在室温下保存1个月,对其结合特性无任何不利影响。 nanoMIP的高亲和力以及对冷链物流的需求使其成为ELISA中使用的传统抗体的有吸引力的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号